serine/threonine Kinase 17b (STK17B) (C-Term) Peptide
STK17B
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits DRAK2 (STK17B)
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Protein Region
- C-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- SSQTQDHSVR SSEDKTSKSS CNGTCGDRED KENIPEDSSM VSKRFRFDDS
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-STK17B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- DRAK2 (STK17B) (serine/threonine Kinase 17b (STK17B))
- Synonymes
- zgc:65989 Peptide, STK17B Peptide, DRAK2 Peptide, Drak2 Peptide, 3110009A03Rik Peptide, AI120141 Peptide, serine/threonine kinase 17b (apoptosis-inducing) Peptide, serine/threonine kinase 17b Peptide, stk17b Peptide, STK17B Peptide, Stk17b Peptide
- Sujet
-
The function of this protein remains unknown.
Alias Symbols: DRAK2
Protein Size: 372 - ID gène
- 9262
- NCBI Accession
- NM_004226, NP_004217
- UniProt
- Q53QE7
-
Vous êtes ici:
